Neuroendocrine carcinoma, technological advacements and rising number of government initiatives have supported long-term expansion of neuroendocrine tumor treatment market. As per Delvens market analysis report, global Neuroendocrine Tumour Treatment market size is projected to reach USD 2,302.3 million by 2027, from USD 1,498.4 million in 2020, at a CAGR of 5.9% during 2021-2028.